A phase 2 study of high dose cyclophosphamide, thiopeta and carboplatin with autologous bone marrow support in women with measurable advanced breast cancer responding to standard dose therapy
Antman K, Ayash L, Wheeler C et al. A phase 2 study of high dose cyclophosphamide, thiopeta and carboplatin with autologous bone marrow support in women with measurable advanced breast cancer responding to standard dose therapy. J Clin Oncol 1992; 10: 102-110.
Intensive chemotherapeutic regimens against acute leukemia transiently suppress asthma symptoms but do not lead to long-term relief
Weigel S, Schmidt SM, Bernig T et al. Intensive chemotherapeutic regimens against acute leukemia transiently suppress asthma symptoms but do not lead to long-term relief. Pediatr Hematol Oncol 2000; 17: 659-665.
The effects of an anti-CD4 monoclonal antibody, keliximab, on peripheral blood CD4+ T-cells in asthma
Kon O, Sihra B, Loh L et al. The effects of an anti-CD4 monoclonal antibody, keliximab, on peripheral blood CD4+ T-cells in asthma. Eur Respir J 2001; 18: 45-52.
Constraints on CD4 recovery postchemotherapy in adults: Thymic insufficiency and apoptotic decline of expanded peripheral CD4 cells
Hakim FT, Cepeda R, Kaimei et al. Constraints on CD4 recovery postchemotherapy in adults: Thymic insufficiency and apoptotic decline of expanded peripheral CD4 cells. Blood 1997; 90: 3789-3798.
Immune reconstitution following high-dose chemotherapy with stem cell rescue in patients with advanced breast cancer
Avigan D, Wu Z, Joyce R et al. Immune reconstitution following high-dose chemotherapy with stem cell rescue in patients with advanced breast cancer. Bone Marrow Transplant 2000; 26: 169-176.
Treatment of severe systemic lupus erythematous with high-dose chemotherapy and haemopoietic stem-cell transplantation: A phase 1 study
Traynor A, Schroeder J, Rosa R et al. Treatment of severe systemic lupus erythematous with high-dose chemotherapy and haemopoietic stem-cell transplantation: A phase 1 study. Lancet 2000; 356: 701-707.